Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, T-Cell

Explore clinical trials studying Lymphoma, T-Cell. Study availability and eligibility vary by location and protocol.

181 public trials 52 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, T-Cell trial results

Recruiting

BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

NCT04752826

Conditions
Adnexal Diseases, Advanced Malignancies, Endocrine Gland Neoplasms, +33 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
  • Rigshospitalet Copenhagen, Denmark
View all 25 locations
View Trial Details
Recruiting

Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma

NCT05079282

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • University of California Irvine Medical Center - Chao Family Comprehensive Cancer Center Orange, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
View all 20 locations
View Trial Details
Recruiting

MB-105 in Patients With CD5 Positive T-cell Lymphoma

NCT06534060

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • University of San Diego (UCSD)-Moores Cancer Center San Diego, California, United States
  • SCRI - Colorado Blood Cancer Institute (CBCI) Denver, Colorado, United States
  • Moffitt Cancer Center Magnolia Campus Tampa, Florida, United States
  • University of Iowa Iowa City, Iowa, United States
View Trial Details
Recruiting

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

NCT04234048

Conditions
Angioimmunoblastic T-cell Lymphoma, Cutaneous T-Cell Lymphoma, Cutaneous T-Cell Lymphoma, Unspecified, +23 more
Locations
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • City of Hope Medical Foundation Duarte, California, United States
  • University of Southern California Los Angeles, California, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
View Trial Details

Related conditions